2, Bank Lane, Off Town Planning Way, Ilupeju, Lagos State, Nigeria
Email: firstname.lastname@example.org, email@example.com
Tel: 01-737-8991; 01-871-3181; 0803-343-1338; 0803-569-9324
Dosage Form, Composition & NAFDAC Registration Number (NRN)
Tablet (NRN:04-3847): Dihydroartemisinin 60 mg; coated tablet.
Pack size: 8 tablets in versicular plates.
Powerful plasmodicide of malaria parasite agamete which quickly controls symptoms. Highly effective against all types of malaria including multi-drug resistant malaria. It has a high safety and low toxicity profile. Reproduction toxicology: increase foetal absorption during pregnancy in mice. No mutation effects were observed.
Following oral administration of Dihydroartemisinin, absorption is rapid and complete, and the active agent takes effect promptly.
Human pharmacokinetics parameters: Oral dosage 2 mg/kg, Tmax = 1.33h, Cmax = 0.71 mg/mL, T½ = 1.57h.
All types of malaria including severe malaria, cerebral malaria and multi-drug resistant malaria.
The drug should be used with care in early period of pregnancy.
No side effects have been reported on clinical dosage. However, very few cases of temporary reticulocyte subsidence have been noted.
Dosage & Administration
Adults and Children: Doses in mg
|Age group||Day 1||Day 2||Day 3||Day 4||Day 5||Day 6||Day 7||Total dose (mg)|
Store in a cool dry place.
Keep out of the reach of children.